NOS2 and breast carcinoma: In tumors of BALB/c mouse breast cancer model, decrease in the average amount of TAMs and the number of M2-like F4/80+CD206+ TAMs and a significant increase in the number of M1-like F4/80+Nos2+ TAMs were observed after the treatment with endostatin [222].